Jeff Kim is the founder of Slingshot Biosciences. Slingshot Biosciences has raised $49M in total funding. Latest round: Series A.
Jeff Kim is the co-founder and CEO of Slingshot Biosciences, which designs and manufactures synthetic cells for R&D, clinical diagnostics, and engineered cell therapies. He is a serial entrepreneur, having also co-founded Radiant Genomics (acquired by Zymergen) and Pattern Ag.
Full founder directory · Investor directory · Company funding database · Fundraising library